复方小花清风藤浸膏抗急性肝损伤作用及对炎症干预作用的机制研究
|
摘要
很多因素都可以引起肝脏损伤,包括外伤导致的肝损伤、化学性肝损伤(包括药物性肝损伤和非药物性肝损伤,主要是由于平时用药及酒精等因素造成的肝脏损伤)以及病毒性肝炎所导致的肝损伤等。其中以病毒性肝炎引起的肝损伤最为常见。我国是HBV感染的高发区,根据1992-1995年全国病毒性肝炎血清流行病学调查,人群HBsAg携带率达9.75%,约1.2亿人。探讨中药对肝脏的保护作用以及抗炎的机制对开发新的抗肝炎药物有重要意义。近年的研究表明:肝炎的发生机制除与引起炎症的病毒有关外,还与机体的免疫机制引起的肝脏损伤有关。炎症的组织学特征是炎性细胞浸润,细胞因子、炎症介质和转录因子等都在肝炎发病的病理过程中起关键性作用。
小花清风藤(Sabia. parviflora Wall. ex Roxb)为苗族民间药物,是清风藤科清风藤属藤本植物,主要分布于云南、广西、贵州等地,以前的研究资料表明,其对甲肝及乙肝的治疗效果均较显著,有很好的利湿退黄和降转氨酶作用。但相关的药理研究资料极少。贵州省科技产业厅立项,对该药进行化学和活性的系统研究,并研制抗肝损伤的新药。复方小花清风藤浸膏主要由小花清风藤、三七、石斛组成,有清肝利胆的功效,主要用于治疗病毒性肝炎。
本研究采用四氯化碳、α-萘异硫氰酸酯、D-氨基半乳糖、卡介苗联合脂多糖诱发四种肝损伤模型,采用生物化学、酶联免疫分析、免疫组织化学、逆转录聚合酶链反应等手段,从肝脏功能、脂质过氧化、细胞因子的表达、肝细胞凋亡以及转录因子的活化等环节探讨了复方小花清风藤浸膏对不同肝损伤模型的保护作用及其对炎症干预作用的相关机制。
第一部分复方小花清风藤对急性肝损伤动物模型的保护作用
1复方小花清风藤对四氯化碳(CCL4)、α-萘异硫氰酸酯(ANIT)致小鼠肝损伤模型的保护作用
目的:研究复方小花清风藤对四氯化碳致急性化学性肝损伤模型及α-萘异硫氰酸酯致胆瘀症模型小鼠血清中转氨酶、碱性磷酸酶及胆红素含量的影响,探讨复方小花清风藤对肝细胞膜通透性和胆汁排泄功能的影响。方法:分别采用四氯化碳皮下注射、α-萘异硫氰酸酯灌胃致小鼠急性肝脏损伤,观察复方小花清风藤对四氯化碳致肝损伤模型小鼠血清中谷丙转氨酶(ALT)及谷草转氨酶(AST)含量的影响;α-萘异硫氰酸酯致肝损伤模型小鼠血清中ALT、AST、碱性磷酸酶(ALP)及总胆红素(T-Bil)含量的影响。结果:两种模型均可见小鼠血清中的转氨酶含量显著升高,α-萘异硫氰酸酯灌胃48小时后,小鼠血清中的ALP及T-Bil显著升高。复方小花清风藤6.5g/kg、3.3g/kg可明显降低四氯化碳致肝损伤模型小鼠血清中的ALT含量,13g/kg、6.5g/kg、
Liver injury can be caused by many factors, including trauma, chemical materials (mostly drugs or alcohol) and hepatic virus, etc. The most common cause is hepatitis virus. HBV infection rate is high in our country. According to the epidemiologic investigation on hepatitis serum in 1992 to 1995, the HBsAg rate arrive 9.75%, this means about 1.2 hundred million people have HbsAg in serum. So it is significant to investigate the protection effect of traditional Chinese medicine and the anti-inflammation mechanism. In recent years, it is proved that hepatitis is related with not only virus, but also the body immune system. The histological sign of inflammatory include leukocyte infiltration, cytokines, inflammatory mediums and transcription factors, etc.
Sabia. parviflora Wall. ex Roxb mainly grow in Yunnan, Guangxi, Guizhou province. The research materials in before show that it has perfect effect on hepatitis A and hepatitis B. The effect of decreasing ALT, AST and T-Bil is even better. But the concerned pharmacological materials are quite few. In this paper, Parviflora compond was mainly composed of Sabia. parviflora Wall. ex Roxb. By the means of biochemical assay, enzyme-linked immunosorbent assay (ELISA), immunohistochemistry (IHC) and molecular biology, effects of Parviflora compond on the inflammatory reaction in acute liver injury models were studied from liver tissue damage, leukocyte infiltrate, cytokine expression and transcription factors activation, etc. The chief results are as follows.
Part One : Protective effects of Parviflora compond on acute liver injury models
1 Protective effects of Parviflora compond on liver injury models induced by CCL4 and ANIT in mice
OBJECTIVE: To study the effects of Parviflora compond on serum ALT, AST, ALP and T-Bil in liver injury models im mice induced by CCL4 and ANIT. METHODS:The two acute liver injury models were established by CCL4 ip and ANIT ig. Serum ALT, AST, ALP, T-Bil was determined. RESULTS:Serum ALT and AST increased in both models. ANIT ig 48 hours later, serum ALP and T-Bil obviously increased. Parviflora compond (6.5g/kg, 3.3g/kg, ig) can significantly decrease serum ALT level in mice of CCl4 liver injury model. Parviflora compond (13g/kg, 6.5g/kg, 3.3g/kg, ig) can decrease serum ALP and T-Bil level in mice of ANIT liver injury model. CONCLUSION:Parviflora compond have
小花清风藤(Sabia. parviflora Wall. ex Roxb)为苗族民间药物,是清风藤科清风藤属藤本植物,主要分布于云南、广西、贵州等地,以前的研究资料表明,其对甲肝及乙肝的治疗效果均较显著,有很好的利湿退黄和降转氨酶作用。但相关的药理研究资料极少。贵州省科技产业厅立项,对该药进行化学和活性的系统研究,并研制抗肝损伤的新药。复方小花清风藤浸膏主要由小花清风藤、三七、石斛组成,有清肝利胆的功效,主要用于治疗病毒性肝炎。
本研究采用四氯化碳、α-萘异硫氰酸酯、D-氨基半乳糖、卡介苗联合脂多糖诱发四种肝损伤模型,采用生物化学、酶联免疫分析、免疫组织化学、逆转录聚合酶链反应等手段,从肝脏功能、脂质过氧化、细胞因子的表达、肝细胞凋亡以及转录因子的活化等环节探讨了复方小花清风藤浸膏对不同肝损伤模型的保护作用及其对炎症干预作用的相关机制。
第一部分复方小花清风藤对急性肝损伤动物模型的保护作用
1复方小花清风藤对四氯化碳(CCL4)、α-萘异硫氰酸酯(ANIT)致小鼠肝损伤模型的保护作用
目的:研究复方小花清风藤对四氯化碳致急性化学性肝损伤模型及α-萘异硫氰酸酯致胆瘀症模型小鼠血清中转氨酶、碱性磷酸酶及胆红素含量的影响,探讨复方小花清风藤对肝细胞膜通透性和胆汁排泄功能的影响。方法:分别采用四氯化碳皮下注射、α-萘异硫氰酸酯灌胃致小鼠急性肝脏损伤,观察复方小花清风藤对四氯化碳致肝损伤模型小鼠血清中谷丙转氨酶(ALT)及谷草转氨酶(AST)含量的影响;α-萘异硫氰酸酯致肝损伤模型小鼠血清中ALT、AST、碱性磷酸酶(ALP)及总胆红素(T-Bil)含量的影响。结果:两种模型均可见小鼠血清中的转氨酶含量显著升高,α-萘异硫氰酸酯灌胃48小时后,小鼠血清中的ALP及T-Bil显著升高。复方小花清风藤6.5g/kg、3.3g/kg可明显降低四氯化碳致肝损伤模型小鼠血清中的ALT含量,13g/kg、6.5g/kg、
Liver injury can be caused by many factors, including trauma, chemical materials (mostly drugs or alcohol) and hepatic virus, etc. The most common cause is hepatitis virus. HBV infection rate is high in our country. According to the epidemiologic investigation on hepatitis serum in 1992 to 1995, the HBsAg rate arrive 9.75%, this means about 1.2 hundred million people have HbsAg in serum. So it is significant to investigate the protection effect of traditional Chinese medicine and the anti-inflammation mechanism. In recent years, it is proved that hepatitis is related with not only virus, but also the body immune system. The histological sign of inflammatory include leukocyte infiltration, cytokines, inflammatory mediums and transcription factors, etc.
Sabia. parviflora Wall. ex Roxb mainly grow in Yunnan, Guangxi, Guizhou province. The research materials in before show that it has perfect effect on hepatitis A and hepatitis B. The effect of decreasing ALT, AST and T-Bil is even better. But the concerned pharmacological materials are quite few. In this paper, Parviflora compond was mainly composed of Sabia. parviflora Wall. ex Roxb. By the means of biochemical assay, enzyme-linked immunosorbent assay (ELISA), immunohistochemistry (IHC) and molecular biology, effects of Parviflora compond on the inflammatory reaction in acute liver injury models were studied from liver tissue damage, leukocyte infiltrate, cytokine expression and transcription factors activation, etc. The chief results are as follows.
Part One : Protective effects of Parviflora compond on acute liver injury models
1 Protective effects of Parviflora compond on liver injury models induced by CCL4 and ANIT in mice
OBJECTIVE: To study the effects of Parviflora compond on serum ALT, AST, ALP and T-Bil in liver injury models im mice induced by CCL4 and ANIT. METHODS:The two acute liver injury models were established by CCL4 ip and ANIT ig. Serum ALT, AST, ALP, T-Bil was determined. RESULTS:Serum ALT and AST increased in both models. ANIT ig 48 hours later, serum ALP and T-Bil obviously increased. Parviflora compond (6.5g/kg, 3.3g/kg, ig) can significantly decrease serum ALT level in mice of CCl4 liver injury model. Parviflora compond (13g/kg, 6.5g/kg, 3.3g/kg, ig) can decrease serum ALP and T-Bil level in mice of ANIT liver injury model. CONCLUSION:Parviflora compond have
引文
1. 王宝恩,张定凤.现代肝脏病学.科学出版社,2003 年 8 月,第一版.
2. 姚云清,张定凤.乙型肝炎病毒 X 基因在乙型肝炎发病机制中的作用.中华传染病杂志,2003 年,21(5):371.
3. Chemin I,Ohgaki H,Chisari FV,et al. Altered expression of hepatic carcinogen metabolizing enzymes with liver injury in HBV transgenic mouse lineages expressing various amounts of hepatitis B surface antigen.Liver,1999,19:81-87.
4. Boni C,Bertoletti A,Penna A,et al.Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest, 1998, 102:968-975.
5. 金荣华,郎振为,姚光弼,等.慢性乙型肝炎患者拉米夫定治疗后肝组织学的改变.中华肝脏病杂志,2003 年,11(9):555.
6. 曾颖玲,叶晓光.乙肝患者血清 TNF的含量与肝损伤程度及病毒复制的关系.广州医学院学报,2002 年,30(3):40.
7. 秦锡虎.TNF-α 与肝细胞损伤.国外医学生理、病理科学与临床分册,1996年,16(4):289.
8. 吕飒,董芳,宋红丽,等.肿瘤坏死因子α在急性肝坏死发生中的作用.中国医科大学学报,2005 年,34(1):54.
9. 臧国庆,周霞秋,俞红,等.肿瘤坏死因子-α诱导肝细胞凋亡在暴发性肝衰竭中的作用.中华消化杂志,2000 年,20(3):163.
10. Yao HW, Li J, Chen JQ, et, al. A 771726, the active metabolite of leflunomide, inhibits TNF-alpha and IL-1 from Kupffer cells. Inflammation. 2004 ,28(2):97-103.
11. 王连江,冯秉安,陈佳宁,等.IL-18 在内毒素诱导大鼠肝损伤中的变化及中药腑安的作用.中国中西医结合外科杂志, 2001 年,7(5):331.
12. Okammuva,Tsutsui H,Komatsu T,et al.Cloning of a new cytokine that induces IFN-γ Production by T cells.Nature,1995,378:88.
13. 潘红英.IL-18 与肝损伤机理研究新进展.浙江医学,2000 年,22(11):702.
14. kamura H,TSutsui H,Komatsu T,et al .Cloning of a new cytokine that induces IFN-Y Production by T- cells. Nature, 1995,378(6552):88.
15. Tsutsui H,Matsui K,Kawada N,et al.IL 一 18 accounts for both TNF-alpha and Fas ligand-mediated hepatotoxic path ways in endotoxin-induced liver injury in mice .J Immunol,1997,159(8):3961.
16. Galle PR,Hofmma WJ,Walczak H,et al.Involvement of the CD95(APO-1/Fas) receptor and ligand in liver damage. J Exp Med,1995,182(5):1223.
17.kamura H,TSutsui H,Komatsu T,et al .Cloning of a new cytokine that induces IFN-Y Production by T-cells.Nature,1995,378(6552):88.
18.Sakao Y, Takeda K,Tsutsui H, et al. IL-18 deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock.Int Immund,1999,11(3):471.
19.Baggiolinh M, Walz A, Stevenl, et al. Neutrophil-activating peptide –l/interleuking a novel cytokine that activates nuetrophils. J Clin Invest, 1989, 84 (4):1045.
20.王新,许才绂,赵国宁,陈岳祥,黄裕新.TNF-α,IL-6 和 IL-8 与慢性肝病的关系.中华传染病杂志,1997;15(2):85-88.
21.王新,许才绂,赵国宁,黄裕新,陈岳祥.慢性肝病患者血清及肝组织中白细胞介素 8 的研究.中华内科杂志,1996;35(12):825-826.
22.Ohira H, Ueno T, Torimura T, Tanikawa K, Kasukawa R. LeukocytC adhesion molecules in the live and plasma cytokine levels in endotoxin-induced rat liver injury. Scand J Gastroenterol,1995,30(10):1027-1035.
23.Yoshimoto T, Okamura H, Tagawa YI,et al. Interleukin 18 together with interleukin 12 inhibits lgE production by induction of interferon-gamma production from activated B ce11s.Proc Natl Acad Sci USA,1997,94(8):3948
24.Tsuji H,Mukaidu N,Harada A,et al.Alleviation of lipopolysaccharide-induced acute liver injury in propionibacterium acnes-primed IFN-gamma deficient mice by a concomitant reduction of TNF - alpha , IL-12 , and IL-18 production.J Immund,1999,162(2):1049
25.孙沛毅,李瑞琴,解渝,等.肝损伤小鼠肝组织氧化/抗氧化平衡的变化及其与 TXA2/PGI2 平衡的关系.中西医结合肝病杂志,1998,8(1):31.
26.Mhm S,Gayyazi A,Ramadori G. Hepatic expression of inducible nitric oxide synthase transcripts in chronic hepatitis C virus infection: relation to hepatic viral load and liver injury. Hepatology, 1997,26(2):451.
27.Sergent O, Moncada S,Palmer RMJ,et al. Nitric oxide : Physiology, pathophysiology and pharmacology, Biochem Mol Bil lnt, 1995, 35(3):575.
28.Kim YM,Talanian RV, Li J,et al. Nitric oxide prevents IL-1 beta and IFN-gamma-inducing facto(IL-18) release from macrophages by inhibiting caspase-l (IL-1 beta-convertiong enzyme).J Immund, 1998,161(8):4122.
29.Baldwin AS Jr.The NF-kappa B and I kappa B protein:new discoveries and insights.Annu Rev Immunol,1996,14:649-683.
30.Zaninoni A,Imperiali FG,Pasquini C,et,al.Cytokine modulation of nuclear factor-kappa B activity in B-chronic lymphocytic leukemia.EXP Hematol,2003,31(3):185-190.
31.Clermont F,Adam E,Dumont JE,et,al.Survival pathways regulating the apoptosis induced by tumour necrosis factor-alpha in primary cultured bovine endothelial cells.Cell Signal,2003,15(5):539-46.
32. Nanji AA,Jokelaine K, Rahemtulla A,et al.Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat.Hepatology,1999,30(4):934.
33.Zwacka RM,Zhou W,Zhang Y,et al. Redox gene therapy for ischemia/reperfusion injury of the liver reduce AP1 and NF-kappa B activaion.Nat Ned,1998,4(6):698.
34.Mirza A, Liu SL, Frizell E,et al.A rol for tissue transglutaminase in hepatic in hepatic injury and fibrogenesis,and its regulation by NF-kappa B.Am J Physiol,1997,272(2 pt1):G281.
35.王永堂,鲁秀敏,蒋建新,等.内毒素肝损伤过程中 Kupffer 细胞 NF-κB 和AP-1 活性变化及其生物学意义.生命科学研究,2002 年,6(3):224.
36.Fukman K, Marubayashi S,Okada K,et al.Effect of lazaroid U-74389G and methylprednisolone on endotoxin-induced shock in mice. Surgery, 1999,125(4):421.
37.Harry D, Anand R,Holt S,et al.Increased sensitivity to endotoxemia in the bile duct ligated cirrhotic rat.Hepatology,1999,30(5):1198.
38.Blazka ME, Dermolec DR, Simeonova P,et al. Acetaminophen-induced hepatotoxcity is associated with early changes in NF-kB and NF-IL6 DNA binding activity.J Inflamm,1995,47(3):138.
39.Limuro Y,Bradford BU,Yanashina S,Rusyn I,et al.The glutathion precursor L-2-oxothiazolidine-4-carboxylic acid protects against liver injury due to chronic enteral exposure in the rat.Hepatology, 2000,31(2): 391.
40.Harry D, Anand R, Holt S, et al. Increased sensitivity to endotoxemia in the bile duct-ligated cirrhotic rat. Hepatology,1999,30(5):1198.
41.Tsukamoto H, Rippe R, Niemela O, et al. Roles of oxidative stress in activation of Kupffer and Ito cells in liver fibrogenesis. J Gastroenterol Hepatol,1995,10 Suppl 1:S50-3.
42.Tsukamoto H, Lin M,Giulivi C, et al. Iron primes hepatic macrophages for NF- kB activation in alcoholic liver injury. Am J Physiol,1999,277(6 pt 1):G1240.
43.Lentsch AB, Yoshidome H, Warner RL,et al. Secretory leukocyte protease inhibitor in mice regulates local and remote organ inflammatory injury induced by hepatic ischemia/reperfusion. Gastroenterology,1999,117(4) 953.
44.Essani NA, Fisher MA, Jaeschke H.Inhibition of NF-kappa B activation by dimethyl sulfoxide correlates with surpression of TNF-alpha formation,reduced ICAM-l genetranscription, and protection against endotoxin-induced liver injury.Shock,1997, 7(2): 90.
45.Nagaki M, Naiki T, Brenner DA,et al. Tumor necrosis factor alpha prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not fas-mediated apoptosis: role of nuclear factor-kappaB. Hepatology,2000,32(6):1272-9.
46.Vamecq J, Latruffe N. Medical significance of peroxisome proliferators-activated receptors. Lancet,1999,354(9173):141-48,
47.Devchand PR,Keller H,Peter JM,et al.The PPARα-leukotrience B4 pathway to inflammation control.Nature,1996,384(6604):39-43.
48.王少发,陈孝平,张万广,等. 过氧化物酶体增殖物激活受体 a 在人肝组织的表达及意义.中华肝脏病杂志,2004 年,12(1):52.
49.赵彩彦,姜玲玲. 过氧化物酶体增殖物激活受体与肝病的关系. 中华肝脏病杂志,2003 年,11(6):382.
50.Kon K,Ikejima K,Hirose M,et al.Pioglitazone Prevents early-Phase hapatic fibrogenesis caused by carbon retrachloride.Biochem Bilphys Res Commun,2002,291:55-61.
51.Marra F , Efsen E , Romanelli RG , et al.Ligands of Peroxisome Proliferator-activated receptor gamma modulate Profibrogenic and Proinflammatory actions in hepatic stellate cell. Gastroenterology, 2000,119:466-478.
52.Kondo T, Suda T, Fukuyama H,et,al. Essential roles of the Fas ligand in the development of hepatitis. Nat Med. 1997,3(4):409-13.
53.王慧芬,胡瑾华,朱克顺,等. 乙型肝炎肝组织 Fas ,FasL 和 HBV 抗原的表达. 中华实验和临床病毒学杂志,2001 年,15 (1):12.
54.Rivero M, Crespo J, Fabrega E,et, al. Apoptosis mediated by the Fas system in the fulminant hepatitis by hepatitis B virus. J Viral Hepat. 2002 ,9(2):107-13.
55.李朝斗.贵州产清风藤科入药植物.中药通报,1987,12(8):451.
56.陈谨,邓赟,唐天君,等.小花清风藤三萜成分的研究.中草药, 2004, 35(1):16.
57.林佳,郝小江,梁光义,等.小花清风藤化学成分的研究.中草药,1999,30(5):334.
58.邓赟,陈谨,陈斌,等.小花清风藤生物碱成分的研究.天然产物研究与开发, 2003,15(4):322.
59.卢永兵.肝病治疗重用三七举隅.中医研究,1995,8(6):40.
60.闰涛,陆保磊.三七治疗慢性肝病疗效观察. 河南中医,2000,20(4):69.
61.张荣华,周子成,洪多伦,等.三七抗肝纤维化的实验研究.第三军医大学学报,2000,22(4):307.
62.高玲,文士铭,胡同增.三七根总皂甙对 SMAO休克家兔肝脏的保护作用.临床麻醉学杂志,2000,16(12):613.
63.丛川.三七总甙片对 38 例慢性肝病血清 HA 的影响.实用中西医结合杂志,1998,11(11):1003.
64.张荣华,周子成,洪多伦,等.三七、虫草菌丝对实验性肝纤维化预防作用的研究.重庆医学,2000,29(6):483.
65.余万桂,谢则平.生三七对肝纤维化小鼠血液流变学的影响.湖北省卫生职工医学院学报,2003,3:7.
66.曹文晓,王宝平,任显芝.三七粉对慢性肝病纤维组织代谢指标的影响.河北中西医结合杂志,1998,7(5):671.
67.刘成海,熊磊,刘平,等.MTT 法观察三七总甙对 NIH/3T3 成纤维细胞毒性作用与增殖的影响.中国中西医结合脾胃杂志,1999,7(4):203.
68.熊磊,刘平,谭英姿,等.三七总甙对肝星状细胞增殖及胶原生成的影响.中西医结合肝病杂志,1999,9(3):19.
69.石小枫,徐曼,刘杞.三七总皂甙对肝纤维化大鼠Ⅰ、Ⅲ型胶原及TGF-β1的影响.中药药理与临床 2001;17(2):7.
70.武凡,张树三,康格非.三七皂甙对肝纤维化大鼠分泌型磷脂酶 A 和肿瘤坏死因子表达的影响.中华肝脏病杂志,2003,11(1):51.
71.吕明德,黄嘉凌,肖定璋,等.三七总皂苷抑制肝细胞钙超载的机制.中国药理学通报,1999,15(2):150.
72.彭宝岗,吕明德,肖定璋.三七总皂甙对大鼠肝细胞钙内流的阻断作用.中国药理学通报,1997,13(1):70.
73.梁力建,何强,吕明德.三七总皂甙对大鼠肝缺血再灌注损伤的保护.新消化病学杂志,1997,5(7):419.
74.姜文泉,元文勇,柳明洙,等. 三七总皂甙对大鼠肝脏短期缺血再灌注损伤早期钙离子含量变化的影响.延边大学医学学报,2001,24(4):260.
75.元文勇,姜文泉,姜帷龙,等. 三七总皂甙在大鼠肝脏缺血再灌注损伤中肝细胞超微结构的保护作用.中国误诊学杂志,2003,3(11):1618.
76.陈少夫,李宇权,吴亚丽. 石斛对胃酸分泌及血清胃泌素、 血浆生长抑素浓度的影响.中国中药杂志,1995,20(3):181.
77.黄玲,施红,章小宛,等.水提和醇提的石斛口服液对衰老药效学指标的影响. 福建中医学院学报,1996,6(3):27.
78.黄玲,施红.醇提的石斛复方制剂抗氧化作用的实验和临床研究.福建中医学院学报,1998 年,8(2):24.
79.赵永灵.兜唇石斛多糖的研究.云南植物研究,1994,16(4):392.
80.黄民权,蔡体育,刘庆伦.铁皮石斛多糖对小白鼠白细胞数和淋巴细胞移动抑制因子的影响.天然药物研究与开发,1996,8(3):39.
81.施红,林智诚,张学敏,等.石斛复方制剂对小鼠腹腔巨噬细胞吞噬功能的作用.福建中医学院学报, 1998,8(3):33.
82.施红,陈玉春,林智诚,等.石斛复方制剂对小鼠免疫功能的影响. 福建中医学院学报, 1996,6(2):24) (施红,陈玉春.石斛复方制剂的抗氧化和免疫功能的相关研究.福建中医学院学报,1997 年,7(4):13.
83.高建平,金若敏,吴耀平,等.铁皮石斛原球茎与原药材免疫调节作用的比较研究.中药材, 2002 年,25(7) 7:487.
84. 方 泰 惠 . 石 斛 对 大 鼠 肠 系 膜 的 动 脉 血 管 的 作 用 . 南 京 中 医 学 院 学报,1991,7(2):100.
85.苏敏,施红.石斛复方制剂对衰老家兔血脂和血粘度的影响.海峡药学,1998年,10(1):13.
86.蔡雪珠,王文,倪正.石斛醇提物对家兔血液流变性与凝固性的影响.微循环技术杂志,1997 年,2:71.
87. 徐建华 ,李莉 , 陈立钻 . 铁皮石斛与西洋参的养阴生津作用研究 .中草药,1995,26(2):79.
88.马雪梅,章萍,于苏萍,等.云南石仙桃及石斛总生物碱和多糖含量的分析.中草药,1997,28(9):561.
89.Miyazawa M et,al.Antimutagenic activity of gogantol from Dendrobium nobile.J Agric Food Chem,1997,45(8):2849.
90.Miyazawa M, Shimamura H, Nakamura S, et,al. Moscatilin from Dendrobium nobile, a naturally occurring bibenzyl compound with potential antimutagenic activity. J Agric Food Chem.1999,47(5):2163.
1.Shah H, Hartman SP, Weinhouse S.Formation of carbonyl chloride in carbon tetrachloride metabolism by rat liver in vitro[J].Cancer 1979,39(10):3942-7.
2.张锦周,庄志雄. 四氯化碳急性染毒对大鼠肝脏脂质过氧化的影响.中国公共卫生学报,1998 年,17(6):341
3.Neubauer K, Eichhorst ST, Wilfling T, et al. Sinusoidal intercellular adhesion molecule-1 up-regulation precedes the accumulation of 1eukocyte function antigen-1-positive cells and tissue necrosis in a model of carbon tetrachloride induced acute rat liver injury[J].Lab Invest,1998,78(2):185-194
4.Kodali P, Wu P, Lahiji PA, et al. ANIT toxicity toward mouse hepatocytes in vivo is mediated primarily by neutrophils via CD18. Am J Physiol Gastrointest Liver Physiol. 2006,Apr 13
5.Chang ML, Yeh CT, Chang PY, et al. Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation. World J Gastroenterol.2005,11(27):4167-72.
6.王鸿利.实验诊断学,人民卫生出版社,2001 年 9 月,第一版
7.蔡皓东,卢书伟,鲁岩.联苯双酯引起肝损害加重 5 例.药物不良反应杂志, 2000 年,3:187-188
8.曹传梅.联苯双酯引起血压升高.药物不良反应杂志,2003 年,6:395
9.白淑梅.联苯双酯致儿童 AST 异常升高.药物不良反应杂志,2003 年,6:400
10.杨怀恩.联苯双酯致腹泻 2 例.新医学,95(10):536
11.李勤朗,苏孝勤,周晓俊.联苯双酯致急性胃绞痛一例.实用医技杂志,1996 年,3(5):382-383
12.卢书伟,蔡皓东.联苯双酯临床适应症的探讨.药物不良反应杂志,2000年,4:225-228
1. D Keppler, R Lesch, W Reutter, K Decker. Experimental hepatitis induced by D-galactosamine[J]. Exp Mol Pathol,1968,9(2):279-90.
2. W Reutter,D Keppler,R Lesch,et al. Glycoprotein metabolism in galactosamine-induced hepatitis[J].Verh Dtsch Ges Inn Med, 1969,75:363-5.
3. D Keppler, J Frohlich, W Reutter, et al.Changes in uridine nucleotides during liver perfusion with D-galactosamine[J].FEBS Lett, 1969,4(4): 278-280.
4. 阎宁,许瑞龄.马来酸二乙酯对半乳糖胺/脂多糖致小鼠急性肝损伤发生中核转录因子表达的影响[J].山西医药杂志,2003,32(6):538.
5. Stachlewitz R F,Seabra V,Bradford B,et,al.Glycine and uridine prevent D-galactosamine hepatotoxicity in the rat:role of Kupffer cells[J]. Hepatology,1999,29:737.
6. Decker K, Keppler D. Galactosamine induced liver injury[J]. Prog Liver Dis.1972,4:183-99.
7. AA Salyers,MO'Brien, SF Kotarski. Galactosamine inhibition of protein synthesis in Bacteroides thetaiotaomicron. Can J Microbiol, November 1, 1983; 29(11): 1532-8.
8. W Bachmann, M Haslbeck, I Bottger,et,al. Reduced insulin binding to hepatic plasma membranes in D-galactosamine-treated rats. Diabetologia, 1979; 17(2): 101-9.
9. 魏屏,彭汉光,黄坤堂,等.加味四逆散对 D-氨基半乳糖所致急性肝损伤大鼠体内脂质过氧化的影响及病理改变同步观察. 同济医科大学学报,2000 年,29(3):268.
10.昌友权,杨世杰,李红,等.肉豆蔻提取物对 GalN 致大鼠急性肝损伤的保护作用.中国药理学通报,2004 年,20(1):118-9.
11.王红梅,张建龙,马琪,等. 大鼠急性肝功不全时血浆中分子物质的变化和肠道吸附剂的作用.新疆医学院学报,1998 年,21(2):105-7.
12. C Schiessel, C Forsthove,D Keppler. 45 Calcium uptake during the transition from reversible to irreversible liver injury induced by D-galactosamine in vivo. Hepatology, 1984, 4(5): 855-61.
13. 徐 萍 , 刘 华 屏 . 常 用 的 急 性 肝 损 伤 动 物 模 型 [J]. 中 国 病 理 生 理 杂志,1995,11(4):447.
14.王伯祥主编.中医肝胆病学.北京:中国医学科技出版社,1993.77
15.顾长海,王宇明主编.急性肝衰竭.成都:四川科学技术出版社,1997.88-954.
16.Feher J, Pollak B, Sreter L, etal. Biochemical markers in carbon-tetrachloride and galactosamine-induced acute liver injuries: the effects of dihydro-quinoline-type antioxi-dants.Br J Exp Path,1982,63:3945.
17.王红,陈在忠.脂质过氧化与肝纤维化.国外医学临床生物化学与检验学分册,1998,19(3):138.
1.王根生.一氧化氮和肿瘤坏死因子在小鼠免疫性肝损伤中的作用及抗肝炎新药 SY801 和 SY640 的影响[J].生理科学进展,1996,27(1):47-9.
2.Ferluga J, Doenhoff MJ, Allison AC. Increased hepatotoxicity of bacterial lipopolysaccharide in mice infected with Schistosomamansoni.Parasite Immunol,1979,1:289-94.
3.Shands JW Jr,Senterfitt VC. Endotoxin induced hepatic damage in BCG infected mice.Am J Pathol,1972,67:23-40.
4.Nagai H, Yakuo I,Yamada H,et,al.Liver injury model in mice for immunopharmacological study.Jpn J Pharmacol,1988,46:247-54.
5.Wang GS, Liu GT. Role of nitric oxide in immunological liver damage in mice[J].Biochem pharmacol,1995,49(9):1277-81.
6. 王 根 生 , 刘 耕 陶 . 一 氧 化 氮 在 小 鼠 肝 损 伤 中 的 作 用 [J]. 中 华 医 学 杂志,1996,76(3):203-6.
1.Blumberg BS, London WT, Sutnick AI, Millman I. Australia antigen, hepatitis and susceptibility to leukemia. Bibl Haematol. 1970;(36):659-77.
2. Shampo MA, Kyle RA. Baruch Blumberg--work on hepatitis B virus. Mayo Clin Proc. 2003 Sep;78(9):1186.
3.斯崇文.乙型肝炎抗病毒治疗策略的探讨.中华内科杂志,2003,42(6):363.
4.曹惠霖.乙型肝炎的流行状况.中国计划免疫.1996 年,2(2):88-90.
5.Patricial LM.Use of animal models to study hepatitis B virus. Prog Med Viral. 1985,35:43.
6.陈乃玲, 刘晓彬. HBV-DNA 定量检测对乙型肝炎的诊断价值.华北国防医药,2002,14(2):127.
7.Chang CN, Skalski V, Hua Zhou J, et al. Biochemical pharmical of (+)-and-(-)2'3'-dideoxy-3'-thiaeytidine as antihepatitis B Virus agents [J] .J Boil Chem, 1992,267:22414.
1.JR MacDonald, JH Beckstead, EA Smuckler. An ultrastructural and histochemical study of the prominent inflammatory response in D(+)-galactosamine hepatotoxicity. Br J Exp Pathol,1987,68(2): 189-99.
2.Stachlewitz R F,Seabra V,Bradford B,et,al.Glycine and uridine prevent D-galactosamine hepatotoxicity in the rat:role of Kupffer cells. Hepatology,1999,29:737.
3. Zhou XD , Zhang BF , Ren H. Prevention of experimental hepatic necrosis by hepatopoietin and monoclonal antibody to TNF [J] . Chin J Infect Dis (in Chinese), 1996 ,14 (3) :137- 140.
4.Wang YM, Ding J , Gu CH ,et al . An in vitro study of mechanisms on lipopolysaccharide/tumor necrosis factor-induced hepatocyte injury in rats[J] . Chin J Infect Dis (in Chinese),1996,14(1):1-5.
5.王宝恩,张定凤.现代肝脏病学.科学出版社,2003 年.397
6.王连江,冯秉安,陈佳宁,等. IL-18 在内毒素诱导大鼠肝损伤中的变化及中药腑安的作用.中国中西医结合外科杂志, 2001 年,7(5):331.
7.kamura H,TSutsui H,Komatsu T,et al.Cloning of a new cytokine that induces IFN-Y Production by T-cells.Nature,1995,378(6552):88
8.Tsutsui H,Matsui K,Kawada N,et al.IL-18 accounts for both TNF-alpha and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury inmice .J Immunol,1997,159(8):3961.
9.潘红英.IL-18 与肝损伤机理研究新进展.浙江医学,2000 年,22(11):702.
10.王新,许才绂,赵国宁,等.TNF-α,IL-6 和 IL-8 与慢性肝病的关系.中华传染病杂志,1997;15(2):85-88.
11.Ohira H, Ueno T, Torimura T, Tanikawa K, Kasukawa R. Leukocyte adhesion molecules in the liver and plasma cytokine levels in endotoxin-induced rat liver injury. Scand J Gastroenterol, 1995,30(10):1027.
1.Galle PR,Kammer PH.CD95-induced apoptosis in human disease. Sentin Liver Dis,1998,18:141-152.
2.Kroemer G.The proto-oncogene Bcl-2and its role in regulating apoptosis.Nature Medicine,1997,3:614-620.
3. Tzung SP,Fausto N,Hockenbery DM.Expression of Bcl-2family during liver regeneration and identification of Bcl-x as a delayed early response gene.Am J Pathol,1997,150(6):1985-1995.
4.金伯泉主编,细胞和分组免疫学,科学出版社,2003,131.
5.Kondo T, Suda T, Fukuyama H,et,al. Essential roles of the Fas ligand in the development of hepatitis. Nat Med. 1997 Apr;3(4):409-13.
6.顾小红,李奇芬,王宇明.丁型肝炎患者肝组织中 Fas/FasL 和肝细胞凋亡表达.世界华人消化杂志,2000,8:35-38.
7.蒋业贵,李奇芬,王宇明.HDV/HBV 感染树鼠肝组织中 Bcl-2/Bax 表达和肝细胞凋亡.世界华人消化杂志,2000,8:625-628.
1.Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu RevImmunol, 1996, 14: 649-683.
2.Matsunaga T, Hokari S, Koyama I, Harada T, Komoda T. NF-kappa B activation in endothelial cells treated with oxidized high-density lipoprotein. Biochem Biophys Res Commun, 2003, 303(1):313-319.
3.Calder VL, Bondeson J, Brennan FM, Foxwell BM, Feldmann M. Antigen-specific T-cell downregulation by human dendritic cells following blockade of NF-kappaB. Scand J Immunol, 2003, 57(3): 261-270.
4.Clermont F, Adam E, Dumont JE, Robaye B. Survival pathways regulating the apoptosis induced by tumour necrosis factor-alpha in primary cultured bovine endothelial cells. Cell Signal, 2003, 15(5):539-46.
5.Zaninoni A, Imperiali FG, Pasquini C, Zanella A, Barcellini W. Cytokine modulation of nuclear factor-kappaB activity in B-chronic lymphocytic leukemia. Exp Hematol, 2003, 31(3): 185-190.
6.王永堂,鲁秀敏,蒋建新,等.内毒素肝损伤过程中枯否细胞 NF-κB 和 AP-1 活性变化及其生物学意义.生命科学研究,2002 年,6(3):224.
7.Fukman K, Marubayashi S,Okada K,et al.Effect of lazaroid U-74389G and methylprednisolone on endotoxin-induced shock in mice. Surgery, 1999,125(4):421.
8.Limuro Y,Bradford BU,Yanashina S,Rusyn I,et al.The glutathion precursor L-2-oxothiazolidine-4-carboxylic acid protects against liver injury due to chronic enteral exposure in the rat.Hepatology, 2000,31(2): 391.
9.Issemann I, Green S. Activation of a number of the steroid receptor superfamily by peroxisome proliferators. Nature, 1990, 347: 645-650.
10.舒茂琴, 何作云. PPARα、PPARγ 核转录因子对单核巨噬细胞作用研究进展. 临床心血管病杂志.2002, 18(6): 283-284.
11.Jiang C, Ting AT, Seed B. PPARγ agonists inhibit production of momocyte inflammatory cytokines.Nature, 1998, 391: 82-86.
12.王少发,陈孝平,张万广,等. 过氧化物酶体增殖物激活受体 a 在人肝组织的表达及意义.中华肝脏病杂志,2004 年,12(1):52.
13.赵彩彦,姜玲玲. 过氧化物酶体增殖物激活受体与肝病的关系. 中华肝脏病杂志,2003 年,11(6):382.
14.Marra F , Efsen E , Romanelli RG , et al.Ligands of Peroxisome Proliferator-activated receptor gamma modulate Profibrogenic and Proinflammatory actions in hepatic stellate cell. Gastroenterology, 2000,119:466-478.
1.刘燕,与细胞凋亡相关的分子和基因研究进展。中国兽药杂志,2002 36(11): 37-40.
2.胡杰英,赵书民,陈奎生.细胞凋亡过程中 c-fos、p53、c-myc 基因的表达,河南肿瘤杂志.1997,10(6):429-431.
3.戴云,张兵,细胞凋亡与细胞内信号,细胞生物学杂志,1997,16(3):58-81.
4.王敬文,施宝民,陶得定,等.肝炎肝硬变患者肝细胞凋亡及其基因调控的检测.实用肝脏病杂志,2000 年,5(1):6.
5.姜勇,韩家准.p38MAPK 信号转导通路.生命科学,1999,11:102 107.
6.Obata T,Brown GE,Yaffe MB. MAP kinase pathways activated by stress: the p38MAPK pathway. Crit Care Med,2000,28:N37 -N77.
7.蔡琪,李晓玫. 丝裂原活化蛋白激酶信号转导通路研究进展.肾脏病与透析肾移植杂志,1999,8(4):354-9.
8.王雨,田伏洲,汤礼军,等.p38 信号转导途径对离体肝脏缺血再灌注损伤的影响.中华肝脏病杂志,2003 年,11(3):170.
9.Rao K MK.Molecular mechanism regulating iNOS explression in various cell types.J Toxicol Environ Health,2000,3:27 58.
2. 姚云清,张定凤.乙型肝炎病毒 X 基因在乙型肝炎发病机制中的作用.中华传染病杂志,2003 年,21(5):371.
3. Chemin I,Ohgaki H,Chisari FV,et al. Altered expression of hepatic carcinogen metabolizing enzymes with liver injury in HBV transgenic mouse lineages expressing various amounts of hepatitis B surface antigen.Liver,1999,19:81-87.
4. Boni C,Bertoletti A,Penna A,et al.Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest, 1998, 102:968-975.
5. 金荣华,郎振为,姚光弼,等.慢性乙型肝炎患者拉米夫定治疗后肝组织学的改变.中华肝脏病杂志,2003 年,11(9):555.
6. 曾颖玲,叶晓光.乙肝患者血清 TNF的含量与肝损伤程度及病毒复制的关系.广州医学院学报,2002 年,30(3):40.
7. 秦锡虎.TNF-α 与肝细胞损伤.国外医学生理、病理科学与临床分册,1996年,16(4):289.
8. 吕飒,董芳,宋红丽,等.肿瘤坏死因子α在急性肝坏死发生中的作用.中国医科大学学报,2005 年,34(1):54.
9. 臧国庆,周霞秋,俞红,等.肿瘤坏死因子-α诱导肝细胞凋亡在暴发性肝衰竭中的作用.中华消化杂志,2000 年,20(3):163.
10. Yao HW, Li J, Chen JQ, et, al. A 771726, the active metabolite of leflunomide, inhibits TNF-alpha and IL-1 from Kupffer cells. Inflammation. 2004 ,28(2):97-103.
11. 王连江,冯秉安,陈佳宁,等.IL-18 在内毒素诱导大鼠肝损伤中的变化及中药腑安的作用.中国中西医结合外科杂志, 2001 年,7(5):331.
12. Okammuva,Tsutsui H,Komatsu T,et al.Cloning of a new cytokine that induces IFN-γ Production by T cells.Nature,1995,378:88.
13. 潘红英.IL-18 与肝损伤机理研究新进展.浙江医学,2000 年,22(11):702.
14. kamura H,TSutsui H,Komatsu T,et al .Cloning of a new cytokine that induces IFN-Y Production by T- cells. Nature, 1995,378(6552):88.
15. Tsutsui H,Matsui K,Kawada N,et al.IL 一 18 accounts for both TNF-alpha and Fas ligand-mediated hepatotoxic path ways in endotoxin-induced liver injury in mice .J Immunol,1997,159(8):3961.
16. Galle PR,Hofmma WJ,Walczak H,et al.Involvement of the CD95(APO-1/Fas) receptor and ligand in liver damage. J Exp Med,1995,182(5):1223.
17.kamura H,TSutsui H,Komatsu T,et al .Cloning of a new cytokine that induces IFN-Y Production by T-cells.Nature,1995,378(6552):88.
18.Sakao Y, Takeda K,Tsutsui H, et al. IL-18 deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock.Int Immund,1999,11(3):471.
19.Baggiolinh M, Walz A, Stevenl, et al. Neutrophil-activating peptide –l/interleuking a novel cytokine that activates nuetrophils. J Clin Invest, 1989, 84 (4):1045.
20.王新,许才绂,赵国宁,陈岳祥,黄裕新.TNF-α,IL-6 和 IL-8 与慢性肝病的关系.中华传染病杂志,1997;15(2):85-88.
21.王新,许才绂,赵国宁,黄裕新,陈岳祥.慢性肝病患者血清及肝组织中白细胞介素 8 的研究.中华内科杂志,1996;35(12):825-826.
22.Ohira H, Ueno T, Torimura T, Tanikawa K, Kasukawa R. LeukocytC adhesion molecules in the live and plasma cytokine levels in endotoxin-induced rat liver injury. Scand J Gastroenterol,1995,30(10):1027-1035.
23.Yoshimoto T, Okamura H, Tagawa YI,et al. Interleukin 18 together with interleukin 12 inhibits lgE production by induction of interferon-gamma production from activated B ce11s.Proc Natl Acad Sci USA,1997,94(8):3948
24.Tsuji H,Mukaidu N,Harada A,et al.Alleviation of lipopolysaccharide-induced acute liver injury in propionibacterium acnes-primed IFN-gamma deficient mice by a concomitant reduction of TNF - alpha , IL-12 , and IL-18 production.J Immund,1999,162(2):1049
25.孙沛毅,李瑞琴,解渝,等.肝损伤小鼠肝组织氧化/抗氧化平衡的变化及其与 TXA2/PGI2 平衡的关系.中西医结合肝病杂志,1998,8(1):31.
26.Mhm S,Gayyazi A,Ramadori G. Hepatic expression of inducible nitric oxide synthase transcripts in chronic hepatitis C virus infection: relation to hepatic viral load and liver injury. Hepatology, 1997,26(2):451.
27.Sergent O, Moncada S,Palmer RMJ,et al. Nitric oxide : Physiology, pathophysiology and pharmacology, Biochem Mol Bil lnt, 1995, 35(3):575.
28.Kim YM,Talanian RV, Li J,et al. Nitric oxide prevents IL-1 beta and IFN-gamma-inducing facto(IL-18) release from macrophages by inhibiting caspase-l (IL-1 beta-convertiong enzyme).J Immund, 1998,161(8):4122.
29.Baldwin AS Jr.The NF-kappa B and I kappa B protein:new discoveries and insights.Annu Rev Immunol,1996,14:649-683.
30.Zaninoni A,Imperiali FG,Pasquini C,et,al.Cytokine modulation of nuclear factor-kappa B activity in B-chronic lymphocytic leukemia.EXP Hematol,2003,31(3):185-190.
31.Clermont F,Adam E,Dumont JE,et,al.Survival pathways regulating the apoptosis induced by tumour necrosis factor-alpha in primary cultured bovine endothelial cells.Cell Signal,2003,15(5):539-46.
32. Nanji AA,Jokelaine K, Rahemtulla A,et al.Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat.Hepatology,1999,30(4):934.
33.Zwacka RM,Zhou W,Zhang Y,et al. Redox gene therapy for ischemia/reperfusion injury of the liver reduce AP1 and NF-kappa B activaion.Nat Ned,1998,4(6):698.
34.Mirza A, Liu SL, Frizell E,et al.A rol for tissue transglutaminase in hepatic in hepatic injury and fibrogenesis,and its regulation by NF-kappa B.Am J Physiol,1997,272(2 pt1):G281.
35.王永堂,鲁秀敏,蒋建新,等.内毒素肝损伤过程中 Kupffer 细胞 NF-κB 和AP-1 活性变化及其生物学意义.生命科学研究,2002 年,6(3):224.
36.Fukman K, Marubayashi S,Okada K,et al.Effect of lazaroid U-74389G and methylprednisolone on endotoxin-induced shock in mice. Surgery, 1999,125(4):421.
37.Harry D, Anand R,Holt S,et al.Increased sensitivity to endotoxemia in the bile duct ligated cirrhotic rat.Hepatology,1999,30(5):1198.
38.Blazka ME, Dermolec DR, Simeonova P,et al. Acetaminophen-induced hepatotoxcity is associated with early changes in NF-kB and NF-IL6 DNA binding activity.J Inflamm,1995,47(3):138.
39.Limuro Y,Bradford BU,Yanashina S,Rusyn I,et al.The glutathion precursor L-2-oxothiazolidine-4-carboxylic acid protects against liver injury due to chronic enteral exposure in the rat.Hepatology, 2000,31(2): 391.
40.Harry D, Anand R, Holt S, et al. Increased sensitivity to endotoxemia in the bile duct-ligated cirrhotic rat. Hepatology,1999,30(5):1198.
41.Tsukamoto H, Rippe R, Niemela O, et al. Roles of oxidative stress in activation of Kupffer and Ito cells in liver fibrogenesis. J Gastroenterol Hepatol,1995,10 Suppl 1:S50-3.
42.Tsukamoto H, Lin M,Giulivi C, et al. Iron primes hepatic macrophages for NF- kB activation in alcoholic liver injury. Am J Physiol,1999,277(6 pt 1):G1240.
43.Lentsch AB, Yoshidome H, Warner RL,et al. Secretory leukocyte protease inhibitor in mice regulates local and remote organ inflammatory injury induced by hepatic ischemia/reperfusion. Gastroenterology,1999,117(4) 953.
44.Essani NA, Fisher MA, Jaeschke H.Inhibition of NF-kappa B activation by dimethyl sulfoxide correlates with surpression of TNF-alpha formation,reduced ICAM-l genetranscription, and protection against endotoxin-induced liver injury.Shock,1997, 7(2): 90.
45.Nagaki M, Naiki T, Brenner DA,et al. Tumor necrosis factor alpha prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not fas-mediated apoptosis: role of nuclear factor-kappaB. Hepatology,2000,32(6):1272-9.
46.Vamecq J, Latruffe N. Medical significance of peroxisome proliferators-activated receptors. Lancet,1999,354(9173):141-48,
47.Devchand PR,Keller H,Peter JM,et al.The PPARα-leukotrience B4 pathway to inflammation control.Nature,1996,384(6604):39-43.
48.王少发,陈孝平,张万广,等. 过氧化物酶体增殖物激活受体 a 在人肝组织的表达及意义.中华肝脏病杂志,2004 年,12(1):52.
49.赵彩彦,姜玲玲. 过氧化物酶体增殖物激活受体与肝病的关系. 中华肝脏病杂志,2003 年,11(6):382.
50.Kon K,Ikejima K,Hirose M,et al.Pioglitazone Prevents early-Phase hapatic fibrogenesis caused by carbon retrachloride.Biochem Bilphys Res Commun,2002,291:55-61.
51.Marra F , Efsen E , Romanelli RG , et al.Ligands of Peroxisome Proliferator-activated receptor gamma modulate Profibrogenic and Proinflammatory actions in hepatic stellate cell. Gastroenterology, 2000,119:466-478.
52.Kondo T, Suda T, Fukuyama H,et,al. Essential roles of the Fas ligand in the development of hepatitis. Nat Med. 1997,3(4):409-13.
53.王慧芬,胡瑾华,朱克顺,等. 乙型肝炎肝组织 Fas ,FasL 和 HBV 抗原的表达. 中华实验和临床病毒学杂志,2001 年,15 (1):12.
54.Rivero M, Crespo J, Fabrega E,et, al. Apoptosis mediated by the Fas system in the fulminant hepatitis by hepatitis B virus. J Viral Hepat. 2002 ,9(2):107-13.
55.李朝斗.贵州产清风藤科入药植物.中药通报,1987,12(8):451.
56.陈谨,邓赟,唐天君,等.小花清风藤三萜成分的研究.中草药, 2004, 35(1):16.
57.林佳,郝小江,梁光义,等.小花清风藤化学成分的研究.中草药,1999,30(5):334.
58.邓赟,陈谨,陈斌,等.小花清风藤生物碱成分的研究.天然产物研究与开发, 2003,15(4):322.
59.卢永兵.肝病治疗重用三七举隅.中医研究,1995,8(6):40.
60.闰涛,陆保磊.三七治疗慢性肝病疗效观察. 河南中医,2000,20(4):69.
61.张荣华,周子成,洪多伦,等.三七抗肝纤维化的实验研究.第三军医大学学报,2000,22(4):307.
62.高玲,文士铭,胡同增.三七根总皂甙对 SMAO休克家兔肝脏的保护作用.临床麻醉学杂志,2000,16(12):613.
63.丛川.三七总甙片对 38 例慢性肝病血清 HA 的影响.实用中西医结合杂志,1998,11(11):1003.
64.张荣华,周子成,洪多伦,等.三七、虫草菌丝对实验性肝纤维化预防作用的研究.重庆医学,2000,29(6):483.
65.余万桂,谢则平.生三七对肝纤维化小鼠血液流变学的影响.湖北省卫生职工医学院学报,2003,3:7.
66.曹文晓,王宝平,任显芝.三七粉对慢性肝病纤维组织代谢指标的影响.河北中西医结合杂志,1998,7(5):671.
67.刘成海,熊磊,刘平,等.MTT 法观察三七总甙对 NIH/3T3 成纤维细胞毒性作用与增殖的影响.中国中西医结合脾胃杂志,1999,7(4):203.
68.熊磊,刘平,谭英姿,等.三七总甙对肝星状细胞增殖及胶原生成的影响.中西医结合肝病杂志,1999,9(3):19.
69.石小枫,徐曼,刘杞.三七总皂甙对肝纤维化大鼠Ⅰ、Ⅲ型胶原及TGF-β1的影响.中药药理与临床 2001;17(2):7.
70.武凡,张树三,康格非.三七皂甙对肝纤维化大鼠分泌型磷脂酶 A 和肿瘤坏死因子表达的影响.中华肝脏病杂志,2003,11(1):51.
71.吕明德,黄嘉凌,肖定璋,等.三七总皂苷抑制肝细胞钙超载的机制.中国药理学通报,1999,15(2):150.
72.彭宝岗,吕明德,肖定璋.三七总皂甙对大鼠肝细胞钙内流的阻断作用.中国药理学通报,1997,13(1):70.
73.梁力建,何强,吕明德.三七总皂甙对大鼠肝缺血再灌注损伤的保护.新消化病学杂志,1997,5(7):419.
74.姜文泉,元文勇,柳明洙,等. 三七总皂甙对大鼠肝脏短期缺血再灌注损伤早期钙离子含量变化的影响.延边大学医学学报,2001,24(4):260.
75.元文勇,姜文泉,姜帷龙,等. 三七总皂甙在大鼠肝脏缺血再灌注损伤中肝细胞超微结构的保护作用.中国误诊学杂志,2003,3(11):1618.
76.陈少夫,李宇权,吴亚丽. 石斛对胃酸分泌及血清胃泌素、 血浆生长抑素浓度的影响.中国中药杂志,1995,20(3):181.
77.黄玲,施红,章小宛,等.水提和醇提的石斛口服液对衰老药效学指标的影响. 福建中医学院学报,1996,6(3):27.
78.黄玲,施红.醇提的石斛复方制剂抗氧化作用的实验和临床研究.福建中医学院学报,1998 年,8(2):24.
79.赵永灵.兜唇石斛多糖的研究.云南植物研究,1994,16(4):392.
80.黄民权,蔡体育,刘庆伦.铁皮石斛多糖对小白鼠白细胞数和淋巴细胞移动抑制因子的影响.天然药物研究与开发,1996,8(3):39.
81.施红,林智诚,张学敏,等.石斛复方制剂对小鼠腹腔巨噬细胞吞噬功能的作用.福建中医学院学报, 1998,8(3):33.
82.施红,陈玉春,林智诚,等.石斛复方制剂对小鼠免疫功能的影响. 福建中医学院学报, 1996,6(2):24) (施红,陈玉春.石斛复方制剂的抗氧化和免疫功能的相关研究.福建中医学院学报,1997 年,7(4):13.
83.高建平,金若敏,吴耀平,等.铁皮石斛原球茎与原药材免疫调节作用的比较研究.中药材, 2002 年,25(7) 7:487.
84. 方 泰 惠 . 石 斛 对 大 鼠 肠 系 膜 的 动 脉 血 管 的 作 用 . 南 京 中 医 学 院 学报,1991,7(2):100.
85.苏敏,施红.石斛复方制剂对衰老家兔血脂和血粘度的影响.海峡药学,1998年,10(1):13.
86.蔡雪珠,王文,倪正.石斛醇提物对家兔血液流变性与凝固性的影响.微循环技术杂志,1997 年,2:71.
87. 徐建华 ,李莉 , 陈立钻 . 铁皮石斛与西洋参的养阴生津作用研究 .中草药,1995,26(2):79.
88.马雪梅,章萍,于苏萍,等.云南石仙桃及石斛总生物碱和多糖含量的分析.中草药,1997,28(9):561.
89.Miyazawa M et,al.Antimutagenic activity of gogantol from Dendrobium nobile.J Agric Food Chem,1997,45(8):2849.
90.Miyazawa M, Shimamura H, Nakamura S, et,al. Moscatilin from Dendrobium nobile, a naturally occurring bibenzyl compound with potential antimutagenic activity. J Agric Food Chem.1999,47(5):2163.
1.Shah H, Hartman SP, Weinhouse S.Formation of carbonyl chloride in carbon tetrachloride metabolism by rat liver in vitro[J].Cancer 1979,39(10):3942-7.
2.张锦周,庄志雄. 四氯化碳急性染毒对大鼠肝脏脂质过氧化的影响.中国公共卫生学报,1998 年,17(6):341
3.Neubauer K, Eichhorst ST, Wilfling T, et al. Sinusoidal intercellular adhesion molecule-1 up-regulation precedes the accumulation of 1eukocyte function antigen-1-positive cells and tissue necrosis in a model of carbon tetrachloride induced acute rat liver injury[J].Lab Invest,1998,78(2):185-194
4.Kodali P, Wu P, Lahiji PA, et al. ANIT toxicity toward mouse hepatocytes in vivo is mediated primarily by neutrophils via CD18. Am J Physiol Gastrointest Liver Physiol. 2006,Apr 13
5.Chang ML, Yeh CT, Chang PY, et al. Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation. World J Gastroenterol.2005,11(27):4167-72.
6.王鸿利.实验诊断学,人民卫生出版社,2001 年 9 月,第一版
7.蔡皓东,卢书伟,鲁岩.联苯双酯引起肝损害加重 5 例.药物不良反应杂志, 2000 年,3:187-188
8.曹传梅.联苯双酯引起血压升高.药物不良反应杂志,2003 年,6:395
9.白淑梅.联苯双酯致儿童 AST 异常升高.药物不良反应杂志,2003 年,6:400
10.杨怀恩.联苯双酯致腹泻 2 例.新医学,95(10):536
11.李勤朗,苏孝勤,周晓俊.联苯双酯致急性胃绞痛一例.实用医技杂志,1996 年,3(5):382-383
12.卢书伟,蔡皓东.联苯双酯临床适应症的探讨.药物不良反应杂志,2000年,4:225-228
1. D Keppler, R Lesch, W Reutter, K Decker. Experimental hepatitis induced by D-galactosamine[J]. Exp Mol Pathol,1968,9(2):279-90.
2. W Reutter,D Keppler,R Lesch,et al. Glycoprotein metabolism in galactosamine-induced hepatitis[J].Verh Dtsch Ges Inn Med, 1969,75:363-5.
3. D Keppler, J Frohlich, W Reutter, et al.Changes in uridine nucleotides during liver perfusion with D-galactosamine[J].FEBS Lett, 1969,4(4): 278-280.
4. 阎宁,许瑞龄.马来酸二乙酯对半乳糖胺/脂多糖致小鼠急性肝损伤发生中核转录因子表达的影响[J].山西医药杂志,2003,32(6):538.
5. Stachlewitz R F,Seabra V,Bradford B,et,al.Glycine and uridine prevent D-galactosamine hepatotoxicity in the rat:role of Kupffer cells[J]. Hepatology,1999,29:737.
6. Decker K, Keppler D. Galactosamine induced liver injury[J]. Prog Liver Dis.1972,4:183-99.
7. AA Salyers,MO'Brien, SF Kotarski. Galactosamine inhibition of protein synthesis in Bacteroides thetaiotaomicron. Can J Microbiol, November 1, 1983; 29(11): 1532-8.
8. W Bachmann, M Haslbeck, I Bottger,et,al. Reduced insulin binding to hepatic plasma membranes in D-galactosamine-treated rats. Diabetologia, 1979; 17(2): 101-9.
9. 魏屏,彭汉光,黄坤堂,等.加味四逆散对 D-氨基半乳糖所致急性肝损伤大鼠体内脂质过氧化的影响及病理改变同步观察. 同济医科大学学报,2000 年,29(3):268.
10.昌友权,杨世杰,李红,等.肉豆蔻提取物对 GalN 致大鼠急性肝损伤的保护作用.中国药理学通报,2004 年,20(1):118-9.
11.王红梅,张建龙,马琪,等. 大鼠急性肝功不全时血浆中分子物质的变化和肠道吸附剂的作用.新疆医学院学报,1998 年,21(2):105-7.
12. C Schiessel, C Forsthove,D Keppler. 45 Calcium uptake during the transition from reversible to irreversible liver injury induced by D-galactosamine in vivo. Hepatology, 1984, 4(5): 855-61.
13. 徐 萍 , 刘 华 屏 . 常 用 的 急 性 肝 损 伤 动 物 模 型 [J]. 中 国 病 理 生 理 杂志,1995,11(4):447.
14.王伯祥主编.中医肝胆病学.北京:中国医学科技出版社,1993.77
15.顾长海,王宇明主编.急性肝衰竭.成都:四川科学技术出版社,1997.88-954.
16.Feher J, Pollak B, Sreter L, etal. Biochemical markers in carbon-tetrachloride and galactosamine-induced acute liver injuries: the effects of dihydro-quinoline-type antioxi-dants.Br J Exp Path,1982,63:3945.
17.王红,陈在忠.脂质过氧化与肝纤维化.国外医学临床生物化学与检验学分册,1998,19(3):138.
1.王根生.一氧化氮和肿瘤坏死因子在小鼠免疫性肝损伤中的作用及抗肝炎新药 SY801 和 SY640 的影响[J].生理科学进展,1996,27(1):47-9.
2.Ferluga J, Doenhoff MJ, Allison AC. Increased hepatotoxicity of bacterial lipopolysaccharide in mice infected with Schistosomamansoni.Parasite Immunol,1979,1:289-94.
3.Shands JW Jr,Senterfitt VC. Endotoxin induced hepatic damage in BCG infected mice.Am J Pathol,1972,67:23-40.
4.Nagai H, Yakuo I,Yamada H,et,al.Liver injury model in mice for immunopharmacological study.Jpn J Pharmacol,1988,46:247-54.
5.Wang GS, Liu GT. Role of nitric oxide in immunological liver damage in mice[J].Biochem pharmacol,1995,49(9):1277-81.
6. 王 根 生 , 刘 耕 陶 . 一 氧 化 氮 在 小 鼠 肝 损 伤 中 的 作 用 [J]. 中 华 医 学 杂志,1996,76(3):203-6.
1.Blumberg BS, London WT, Sutnick AI, Millman I. Australia antigen, hepatitis and susceptibility to leukemia. Bibl Haematol. 1970;(36):659-77.
2. Shampo MA, Kyle RA. Baruch Blumberg--work on hepatitis B virus. Mayo Clin Proc. 2003 Sep;78(9):1186.
3.斯崇文.乙型肝炎抗病毒治疗策略的探讨.中华内科杂志,2003,42(6):363.
4.曹惠霖.乙型肝炎的流行状况.中国计划免疫.1996 年,2(2):88-90.
5.Patricial LM.Use of animal models to study hepatitis B virus. Prog Med Viral. 1985,35:43.
6.陈乃玲, 刘晓彬. HBV-DNA 定量检测对乙型肝炎的诊断价值.华北国防医药,2002,14(2):127.
7.Chang CN, Skalski V, Hua Zhou J, et al. Biochemical pharmical of (+)-and-(-)2'3'-dideoxy-3'-thiaeytidine as antihepatitis B Virus agents [J] .J Boil Chem, 1992,267:22414.
1.JR MacDonald, JH Beckstead, EA Smuckler. An ultrastructural and histochemical study of the prominent inflammatory response in D(+)-galactosamine hepatotoxicity. Br J Exp Pathol,1987,68(2): 189-99.
2.Stachlewitz R F,Seabra V,Bradford B,et,al.Glycine and uridine prevent D-galactosamine hepatotoxicity in the rat:role of Kupffer cells. Hepatology,1999,29:737.
3. Zhou XD , Zhang BF , Ren H. Prevention of experimental hepatic necrosis by hepatopoietin and monoclonal antibody to TNF [J] . Chin J Infect Dis (in Chinese), 1996 ,14 (3) :137- 140.
4.Wang YM, Ding J , Gu CH ,et al . An in vitro study of mechanisms on lipopolysaccharide/tumor necrosis factor-induced hepatocyte injury in rats[J] . Chin J Infect Dis (in Chinese),1996,14(1):1-5.
5.王宝恩,张定凤.现代肝脏病学.科学出版社,2003 年.397
6.王连江,冯秉安,陈佳宁,等. IL-18 在内毒素诱导大鼠肝损伤中的变化及中药腑安的作用.中国中西医结合外科杂志, 2001 年,7(5):331.
7.kamura H,TSutsui H,Komatsu T,et al.Cloning of a new cytokine that induces IFN-Y Production by T-cells.Nature,1995,378(6552):88
8.Tsutsui H,Matsui K,Kawada N,et al.IL-18 accounts for both TNF-alpha and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury inmice .J Immunol,1997,159(8):3961.
9.潘红英.IL-18 与肝损伤机理研究新进展.浙江医学,2000 年,22(11):702.
10.王新,许才绂,赵国宁,等.TNF-α,IL-6 和 IL-8 与慢性肝病的关系.中华传染病杂志,1997;15(2):85-88.
11.Ohira H, Ueno T, Torimura T, Tanikawa K, Kasukawa R. Leukocyte adhesion molecules in the liver and plasma cytokine levels in endotoxin-induced rat liver injury. Scand J Gastroenterol, 1995,30(10):1027.
1.Galle PR,Kammer PH.CD95-induced apoptosis in human disease. Sentin Liver Dis,1998,18:141-152.
2.Kroemer G.The proto-oncogene Bcl-2and its role in regulating apoptosis.Nature Medicine,1997,3:614-620.
3. Tzung SP,Fausto N,Hockenbery DM.Expression of Bcl-2family during liver regeneration and identification of Bcl-x as a delayed early response gene.Am J Pathol,1997,150(6):1985-1995.
4.金伯泉主编,细胞和分组免疫学,科学出版社,2003,131.
5.Kondo T, Suda T, Fukuyama H,et,al. Essential roles of the Fas ligand in the development of hepatitis. Nat Med. 1997 Apr;3(4):409-13.
6.顾小红,李奇芬,王宇明.丁型肝炎患者肝组织中 Fas/FasL 和肝细胞凋亡表达.世界华人消化杂志,2000,8:35-38.
7.蒋业贵,李奇芬,王宇明.HDV/HBV 感染树鼠肝组织中 Bcl-2/Bax 表达和肝细胞凋亡.世界华人消化杂志,2000,8:625-628.
1.Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu RevImmunol, 1996, 14: 649-683.
2.Matsunaga T, Hokari S, Koyama I, Harada T, Komoda T. NF-kappa B activation in endothelial cells treated with oxidized high-density lipoprotein. Biochem Biophys Res Commun, 2003, 303(1):313-319.
3.Calder VL, Bondeson J, Brennan FM, Foxwell BM, Feldmann M. Antigen-specific T-cell downregulation by human dendritic cells following blockade of NF-kappaB. Scand J Immunol, 2003, 57(3): 261-270.
4.Clermont F, Adam E, Dumont JE, Robaye B. Survival pathways regulating the apoptosis induced by tumour necrosis factor-alpha in primary cultured bovine endothelial cells. Cell Signal, 2003, 15(5):539-46.
5.Zaninoni A, Imperiali FG, Pasquini C, Zanella A, Barcellini W. Cytokine modulation of nuclear factor-kappaB activity in B-chronic lymphocytic leukemia. Exp Hematol, 2003, 31(3): 185-190.
6.王永堂,鲁秀敏,蒋建新,等.内毒素肝损伤过程中枯否细胞 NF-κB 和 AP-1 活性变化及其生物学意义.生命科学研究,2002 年,6(3):224.
7.Fukman K, Marubayashi S,Okada K,et al.Effect of lazaroid U-74389G and methylprednisolone on endotoxin-induced shock in mice. Surgery, 1999,125(4):421.
8.Limuro Y,Bradford BU,Yanashina S,Rusyn I,et al.The glutathion precursor L-2-oxothiazolidine-4-carboxylic acid protects against liver injury due to chronic enteral exposure in the rat.Hepatology, 2000,31(2): 391.
9.Issemann I, Green S. Activation of a number of the steroid receptor superfamily by peroxisome proliferators. Nature, 1990, 347: 645-650.
10.舒茂琴, 何作云. PPARα、PPARγ 核转录因子对单核巨噬细胞作用研究进展. 临床心血管病杂志.2002, 18(6): 283-284.
11.Jiang C, Ting AT, Seed B. PPARγ agonists inhibit production of momocyte inflammatory cytokines.Nature, 1998, 391: 82-86.
12.王少发,陈孝平,张万广,等. 过氧化物酶体增殖物激活受体 a 在人肝组织的表达及意义.中华肝脏病杂志,2004 年,12(1):52.
13.赵彩彦,姜玲玲. 过氧化物酶体增殖物激活受体与肝病的关系. 中华肝脏病杂志,2003 年,11(6):382.
14.Marra F , Efsen E , Romanelli RG , et al.Ligands of Peroxisome Proliferator-activated receptor gamma modulate Profibrogenic and Proinflammatory actions in hepatic stellate cell. Gastroenterology, 2000,119:466-478.
1.刘燕,与细胞凋亡相关的分子和基因研究进展。中国兽药杂志,2002 36(11): 37-40.
2.胡杰英,赵书民,陈奎生.细胞凋亡过程中 c-fos、p53、c-myc 基因的表达,河南肿瘤杂志.1997,10(6):429-431.
3.戴云,张兵,细胞凋亡与细胞内信号,细胞生物学杂志,1997,16(3):58-81.
4.王敬文,施宝民,陶得定,等.肝炎肝硬变患者肝细胞凋亡及其基因调控的检测.实用肝脏病杂志,2000 年,5(1):6.
5.姜勇,韩家准.p38MAPK 信号转导通路.生命科学,1999,11:102 107.
6.Obata T,Brown GE,Yaffe MB. MAP kinase pathways activated by stress: the p38MAPK pathway. Crit Care Med,2000,28:N37 -N77.
7.蔡琪,李晓玫. 丝裂原活化蛋白激酶信号转导通路研究进展.肾脏病与透析肾移植杂志,1999,8(4):354-9.
8.王雨,田伏洲,汤礼军,等.p38 信号转导途径对离体肝脏缺血再灌注损伤的影响.中华肝脏病杂志,2003 年,11(3):170.
9.Rao K MK.Molecular mechanism regulating iNOS explression in various cell types.J Toxicol Environ Health,2000,3:27 58.